In David Eisenberg's lab at UCLA, researchers focus on developing new treatments for Alzheimer’s Disease by studying the structures of toxic proteins in the brain. They utilize advanced imaging techniques to uncover the shapes of these protein aggregates, which contribute to dementia. The lab aims to design drugs that can disrupt and dissolve these harmful aggregates while testing their effectiveness in lab-grown mini-brains, offering a more relevant model for human brain health.

Dr. Paul T. Spellman's lab at UCLA focuses on understanding how genetic factors influence the development and aggressiveness of prostate cancer. The lab investigates the role of germline genomic variations in the evolution of prostate cancer, aiming to improve risk assessment and treatment strategies for this common and serious disease. By analyzing large patient cohorts and using advanced bioinformatics methods, they seek to uncover insights that can help predict the risk of aggressive prostate cancer in men.

Dr. Amy Goldberg's lab at UCLA focuses on understanding how malaria parasites, particularly those that come from primate populations, can infect humans and lead to outbreaks. By studying the genetics of these parasites, especially a type called P. simium from Brazil, the lab aims to uncover the changes that allow these parasites to jump from one species to another. This research is crucial for predicting and preventing new malaria cases and developing effective treatments.

Dr. Karen Reue's lab at UCLA focuses on understanding how genetic factors, particularly on the X chromosome, influence obesity and related cardiovascular disease risks in women. They explore how the Kdm5c gene affects fat storage and energy balance, especially during menopause, aiming to uncover how sex differences play a role in these health issues. Ultimately, this research seeks to inform better prevention strategies for obesity and cardiovascular disease in both genders.

Dr. Paivi Pajukanta's lab at UCLA focuses on understanding how obesity affects health, particularly in regards to cardiometabolic diseases like diabetes and liver disease. The lab conducts cutting-edge research using advanced techniques like single-cell RNA sequencing to uncover the genetic and environmental factors that influence these diseases. Their ultimate goal is to identify ways to prevent or delay the onset of these diseases, especially considering the differences between sexes in disease predisposition.

Dr. Chongyuan Luo's lab at UCLA focuses on understanding the genetic and epigenetic mechanisms that drive cell identity changes, particularly how somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs). The research also aims to map the diverse cell types in developing human brains and their regulatory programs, which could inform our understanding of neuropsychiatric disorders. By using advanced genomic techniques, the lab seeks to uncover the complex networks that govern how cells change identity and function during development and reprogramming processes.

Dr. Marc A. Suchard's lab at UCLA focuses on the development of advanced statistical models and software to study the behavior and spread of rapidly evolving pathogens like viruses. Their research combines data science, evolutionary biology, and infectious disease principles to analyze large datasets from outbreaks, helping to improve public health responses. The lab aims to create scalable tools that can handle extensive epidemiological data, thereby informing better intervention strategies for viral diseases.